Literature DB >> 9622237

Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect.

J Sandin1, I Nylander, J Georgieva, P A Schött, S O Ogren, L Terenius.   

Abstract

The hippocampus plays a central role in the acquisition and storage of information. Long-term potentiation in the mossy fibre pathway to the CA3 region in the hippocampus, an animal model of memory acquisition, is modulated by dynorphin peptides. This study investigated the possible role of hippocampal dynorphin in spatial learning. Male rats were trained in the Morris Water Task after microinjection with different doses of dynorphin B (1, 3.3 or 10 nmol/rat) or artificial cerebrospinal fluid (as control) into the CA3 region of the dorsal hippocampus. Dynorphin B was found to impair spatial learning at all tested doses. The synthetic kappa1-selective opiate receptor antagonist nor-binaltorphimine (2 nmol) also given into the hippocampus fully blocked the acquisition impairment caused by dynorphin B (10 nmol), while nor-binaltorphimine alone did not affect learning performance. These findings suggest that dynorphin peptides could play a modulatory role in hippocampal plasticity by acting on hippocampal kappa-receptors and thereby impair spatial learning.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622237     DOI: 10.1016/s0306-4522(97)00605-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Effect of adenoviral delivery of prodynorphin gene on experimental inflammatory pain induced by formalin in rats.

Authors:  Xionggang Chen; Tingting Wang; Caizhu Lin; Baihong Chen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Memory-enhancing effect of aspirin is mediated through opioid system modulation in an AlCl3-induced neurotoxicity mouse model.

Authors:  Saima Rizwan; Ayesha Idrees; Muhammad Ashraf; Touqeer Ahmed
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

4.  Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.

Authors:  Abigail G Schindler; Shuang Li; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2010-05-05       Impact factor: 7.853

5.  The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.

Authors:  Hugo A Tejeda; Vladimir I Chefer; Agustin Zapata; Toni S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

Review 6.  Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.

Authors:  Brendan M Walker; Glenn R Valdez; Jay P McLaughlin; Georgy Bakalkin
Journal:  Alcohol       Date:  2012-03-27       Impact factor: 2.405

7.  Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitarius.

Authors:  Takayuki Endoh
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

8.  Opioid regulation of spinal cord plasticity: evidence the kappa-2 opioid receptor agonist GR89696 inhibits learning within the rat spinal cord.

Authors:  Stephanie N Washburn; Marissa L Maultsby; Denise A Puga; James W Grau
Journal:  Neurobiol Learn Mem       Date:  2007-11-05       Impact factor: 2.877

9.  The role of calsenilin/DREAM/KChIP3 in contextual fear conditioning.

Authors:  Jon C Alexander; Carmel M McDermott; Tumay Tunur; Vicky Rands; Claire Stelly; Debra Karhson; Mark R Bowlby; W Frank An; J David Sweatt; Laura A Schrader
Journal:  Learn Mem       Date:  2009-02-17       Impact factor: 2.460

10.  Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H.

Authors:  Marian L Logrip; Patricia H Janak; Dorit Ron
Journal:  Alcohol       Date:  2009-08       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.